Shingles pain breakthrough? injections may beat standard drugs

NCT ID NCT06344403

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests whether injecting a mix of lidocaine and steroids into tender points can better relieve shingles pain compared to standard painkillers alone. The trial involves 136 adults with severe shingles pain for less than 90 days. Researchers will track pain levels for up to 12 months to see if the injections reduce the chance of long-term nerve pain.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

lidocaine and diprospan (steroid) injected into tender points

What this could lead to

If it works, this could offer a more effective way to manage shingles pain and reduce the risk of long-term nerve pain.

What could go wrong

This is a small, early-stage trial with no phase designation, so results may not be conclusive. The injections carry risks like infection or allergic reaction.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HERPES ZOSTER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Acute Pain herpes zoster

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beijing Tiantan Hospital

    Beijing, Beijing Municipality, 100070, China